Beneficial effects of the combination of BCc1 and Hep-S nanochelating-based medicines on IL-6 in hospitalized moderate COVID-19 adult patients: a randomized, double-blind, placebo-controlled clinical trial.
Maryam HafiziSomayeh KalanakySaideh FakharzadehPegah KarimiAtefeh FakharianSomayeh LookzadehEsmaeil MortazMaryam Sadat MirenayatJalal HeshmatniaMehrdad Bakhshayesh KaramHoma ZamaniAlireza NadjiMihan Pourabdollah ToutkaboniSaeed Oraee-YazdaniMohammad Esmaeil AkbariHamidreza JamaatiMohammad Hassan NazaranPublished in: Trials (2023)
Iranian Registry of Clinical Trials RCT20170731035423N2 . Registered on June 12, 2020.